A physiologically based pharmacokinetic model of rifampin in mice. - Wikidata - awgldk - TriplyDB

A physiologically based pharmacokinetic model of rifampin in mice.

A physiologically based pharmacokinetic model of rifampin in mice.

http://www.wikidata.org/entity/Q36757635

about

A multi-scale approach to designing therapeutics for tuberculosis A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.Development of a Multicompartment Permeability-Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs.Sensitization of Gram-negative bacteria to rifampin and OAK combinations.Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling.A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice

P2860

Q28647309-A9984427-B150-49AC-974E-F229BEF73899 Q28649754-C7953262-376F-4C16-BBF1-3D86F8A7B83C Q35864589-811BD37E-44F6-43DE-9341-0290D1FDF536 Q36157986-73912567-3B60-4274-8429-63B4594737DA Q37120003-97063D58-8FBB-4D69-93DA-CD5BB1EAB7C9 Q37507317-1EDEA754-8D98-40D2-B648-26BEBA9DAD47 Q39923957-34ACEC41-7E3E-4C30-816A-A5C56282F6F0 Q40358160-4612FE89-FD96-4EFA-92E9-F4994A87AEBF Q41420121-E1C7DCC6-5480-4477-A196-EDBB68E9F56B Q42269559-CF790E8A-5E21-413B-82EF-84F071B8C580 Q46578287-C8963FBE-1E4E-40A0-A29C-381DE0A6A1A0 Q55222613-1545B350-D052-4DC0-8D83-7D607BB37271 Q57175587-7CFC3076-DE3C-4A5A-9C9B-121B9FABCC73

P2860

A physiologically based pharmacokinetic model of rifampin in mice.

http://www.wikidata.org/entity/Q36757635

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A physiologically based pharmacokinetic model of rifampin in mice.

@ast

A physiologically based pharmacokinetic model of rifampin in mice.

@en

type

label

A physiologically based pharmacokinetic model of rifampin in mice.

@ast

A physiologically based pharmacokinetic model of rifampin in mice.

@en

prefLabel

A physiologically based pharmacokinetic model of rifampin in mice.

@ast

A physiologically based pharmacokinetic model of rifampin in mice.

@en

P1433

Q36757635-4C84C8C8-D120-4C4B-B8BD-56A9C841011B

P1476

Q36757635-3489EDA7-C881-4AC2-9E64-EFE379B6EFFF

P2093

Q36757635-2B1E3997-DBF8-44F6-9CC6-0468E73EAE4C

Q36757635-2EC72F1E-F023-440B-B889-4F14FC9C5BD2

Q36757635-D7F29382-9C88-444F-A3C0-5182C0D15C3D

P2860

Q36757635-1B7B0C61-BA0F-4C9D-8417-34336D5C6FA6

Q36757635-1D180562-192A-4695-90D5-A2E56528E4F0

Q36757635-1E03DB0F-C809-41AF-B0B5-5982E4D93093

Q36757635-201F511F-C364-4E8F-817B-421E37A106D2

Q36757635-20F0598F-21A3-49AA-85A2-FAF1FA024858

Q36757635-22ED9F42-9D47-4DBB-8276-FA7D07D75773

Q36757635-23EFAC62-7DBF-4C96-9B10-9FDE0F092199

Q36757635-244DA0B2-734D-4F19-966C-0DA466BC5FCB

Q36757635-29199380-DCFC-4E70-A670-16722C5D5B4B

Q36757635-2930FC10-6A55-4D30-9D1B-99E37781ECC6

P304

Q36757635-40646B10-278F-4E5D-9715-EFCECF14819A

P31

Q36757635-E0A36774-A1E0-425E-AB06-DC1C09E3713A

P356

Q36757635-68334444-7CBA-4492-8B35-428145BE0891

P407

Q36757635-CABC943E-9B4E-4740-B4EC-A9D7D8D86A31

P433

Q36757635-18B0DD5C-53AD-47E2-8B7E-8913E5EFAFE9

P478

Q36757635-772A97BB-CAF3-485A-A977-620F6F53E6F6

P50

Q36757635-A096699E-26F9-4537-BB78-9D3F9CBC484C

P577

Q36757635-31921A59-A46D-4AAE-B92E-5B80B3A9EF05

P5875

Q36757635-94ED595B-8D66-447B-8653-FE3C7957380A

P698

Q36757635-DB272552-EC90-4B78-9D62-DB7D134E7C01

P932

Q36757635-52584F6C-AD2A-42B6-84FE-D7A57BB085AE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

A physiologically based pharmacokinetic model of rifampin in mice

@en

P2093

Anne J Lenaerts

http://www.w3.org/2001/XMLSchema#string

Michael A Lyons

http://www.w3.org/2001/XMLSchema#string

Raymond S H Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

A general model for the origin of allometric scaling laws in biology

Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice

Ipr1 gene mediates innate immunity to tuberculosis.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

PA-824 exhibits time-dependent activity in a murine model of tuberculosis.

PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure.

Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.

P304

1763-1771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01567-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235379258

http://www.w3.org/2001/XMLSchema#string

P698

23357766

http://www.w3.org/2001/XMLSchema#string

P932

3623338

http://www.w3.org/2001/XMLSchema#string